Astex Pharmaceuticals, Inc.
299 articles with Astex Pharmaceuticals, Inc.
-
Mayne Pharma Limited Completes Purchase Of SuperGen, Inc.'s North American Oncology Products; Mayne Pharma To Pay $34 Million
8/23/2006
-
SuperGen, Inc. Reports 2006 Second Quarter Financial Results
7/28/2006
-
SuperGen, Inc. Announces Second Quarter 2006 Financial Results Conference Call To Be Webcast July 27, 2006
7/17/2006
-
The Day In Review: MGI PHARMA, INC. Sells Ex-US Dacogen Rights
7/6/2006
-
SuperGen, Inc. Announces Attainment Of Milestone From The MGI PHARMA, INC. / Cilag GmbH, A Johnson & Johnson, Licensing For Dacogen(TM) (Decitabine) For Injection
7/6/2006
-
MGI PHARMA, INC., SuperGen, Inc. License Treatment To Johnson & Johnson Unit; Total Payments Could Reach $80 Million
7/6/2006
-
SuperGen, Inc. Announces Conference Call And Webcast
6/22/2006
-
Mayne Pharma Limited Acquires SuperGen, Inc.'s North American Oncology Products For A Total Maximum Consideration Of $34 Million
6/22/2006
-
SuperGen, Inc. To Present At Jefferies Life Sciences Conference
6/21/2006
-
SuperGen, Inc. Completes Contract To Transition Wyeth Distribution Of Nipent(R), Outside Of The U.S.
6/6/2006
-
SuperGen, Inc. Receives U.S. Patent For Nipent(R)(Pentostatin For Injection)
6/2/2006
-
SuperGen, Inc. Announces Achievement Of $20 Million Dacogen(TM) (Decitabine) Injection Milestone
5/26/2006
-
SuperGen, Inc. To Webcast Analyst & Investor Day
5/19/2006
-
SuperGen, Inc. To Present At Rodman & Renshaw Global Healthcare Conference
5/11/2006
-
U.S. FDA Approves MGI PHARMA, INC.'s Dacogen(TM) (Decitabine) For Injection
5/3/2006
-
The Day In Review: Biogen Idec, Inc. (Massachusetts) Buys Cancer Company Conforma Therapeutics Corporation
5/3/2006
-
The Day In Review: SuperGen, Inc. Drug Disappoints
4/26/2006
-
SuperGen, Inc. Says Phase II Cancer Drug Fails To Meet Goal
4/26/2006
-
SuperGen, Inc. To Present At RedChip Small-Cap Investor Conference
4/21/2006
-
SuperGen, Inc. Reports 2006 First Quarter Financial Results
4/21/2006